Page last updated: 2024-09-05

sb 203580 and daunorubicin

sb 203580 has been researched along with daunorubicin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(daunorubicin)
Trials
(daunorubicin)
Recent Studies (post-2010) (daunorubicin)
3,48941,1378,2398861,310

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)daunorubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)1.9
Multidrug resistance-associated protein 1 Homo sapiens (human)8
Histone deacetylase 1Homo sapiens (human)0.047
Histone deacetylase 8Homo sapiens (human)0.22
Histone deacetylase 6Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, YB; Jin, MH; Li, Y; Ma, JJ; Peng, RY; Song, LW; Wang, DW1

Other Studies

1 other study(ies) available for sb 203580 and daunorubicin

ArticleYear
[Effects of SB203580 and WP631 on Smad signal transduction pathway in lung fibroblasts after irradiation].
    Ai zheng = Aizheng = Chinese journal of cancer, 2008, Volume: 27, Issue:7

    Topics: Cyclin-Dependent Kinase Inhibitor p21; Daunorubicin; DNA; Fibroblasts; Gamma Rays; Humans; Imidazoles; Lung; Plasminogen Activator Inhibitor 1; Pyridines; Signal Transduction; Smad Proteins; Sp1 Transcription Factor; Transcription Factor AP-1; Transforming Growth Factor beta1

2008